Juli Miller | Investor Relations |
Adrian Rawcliffe | Chief Executive Officer |
Dennis Williams | Senior Vice President, Late Stage Development |
Elliot Norry | Chief Medical Officer |
Gavin Wood | Chief Financial Officer |
Tony Butler | EF Hutton |
Marc Frahm | TD Cowen |
Jonathan Chang | Leerink Partners |
Mara Goldstein | Mizuho |
Good morning, ladies and gentlemen and welcome to Adaptimmune’s Q2 Financial and Business Update Conference Call. I would now like to turn the meeting call over to Ms. Juli Miller. Please go ahead, Ms. Miller.